Labetuzumab govitecan
Product Specifications
CAS Number
1469876-18-3
Specifications
3.8
Synonyms
IMMU-130
Target
Antibody-Drug Conjugate
Applications
Others
Additionnal Information
Labetuzumab govitecan (IMMU-135) is a humanised anti-CEACAM5 (carcinoembryonic antigen-related cell adhesion molecule 5) antibody linked site-specifically to the active metabolite of irinotecan SN-38 via a proprietary linker. Labetuzumab govitecan can be used for research on colorectal cancer.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog